BioPharm America 2015 presents Biomarkers and Precision Medicine

BioPharm America™ 2017: Morphic Therapeutics finds new approach for reaching targetsПодробнее

BioPharm America™: Interview with Christopher Viehbacher, Gurnet Point CapitalПодробнее

BioPharm America™: Interview with Jeremy Levin, Ovid TherapeuticsПодробнее

BioPharm America™: Interview with Sarah Frew, University of PennsylvaniaПодробнее

BioPharm America 2014: Interview with Roger Pomerantz, Seres HealthПодробнее

BioPharm America™ goes digitalПодробнее

BioPharm America™: Interview with Jeremy Levin, Ovid TherapeuticsПодробнее

Precision Medicine Models and BiomarkersПодробнее

BioPharm America 2014: Interview with Gary Nabel, SanofiПодробнее

Biomarkers driving precision medicine in strokeПодробнее

Precision Medicine and BioethicsПодробнее

Biomarker Testing & Precision MedicineПодробнее

BioPharm America 2014: Interview with Jeffrey Stein, Cidara TherapeuticsПодробнее

Biomarkers, Analytics, and the Data-Driven Future of Precision Medicine (Ariel Stern)Подробнее

BioPharm America™ 2016: Denmark-based biotech Curasight making strides in cancer therapiesПодробнее

PREVIEW: Visionaries - Kridel on Biotech in 20 YearsПодробнее

BioPharm America™ in the biotech hub of BostonПодробнее

Precision medicine: Trial enrichment, biomarker science, and mechanistic reasoningПодробнее

2015 MassBio Annual Meeting - Precision Medicine: Where's the Opportunity?Подробнее